Stockscreener 앱 받기
1.18
1.72%
0.02
시간 외 거래:
1.17
-0.01
-0.85%
Femasys Inc 주식(FEMY)의 최신 뉴스
Geode Capital Management LLC Acquires 9,681 Shares of Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Inc. (NASDAQ:FEMY) Sees Significant Drop in Short Interest - Defense World
Femasys (NASDAQ:FEMY) Stock Price Down 3.2% – Time to Sell? - Defense World
FEMY’s 52-Week Rollercoaster: From $0.86 to $1.80 – What’s Next for Investors? - investchronicle.com
FemBloc Delivery System Approved by European Regulators - Medical Product Outsourcing
Femasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be Optimistic - Asianet Newsable
HC Wainwright Reaffirms “Buy” Rating for Femasys (NASDAQ:FEMY) - Defense World
Femasys Positioned for Growth with Innovative Products and Strategic Partnerships - TipRanks
H.C. Wainwright maintains Femasys stock Buy rating, $15 target By Investing.com - Investing.com India
H.C. Wainwright maintains Femasys stock Buy rating, $15 target - Investing.com
Femasys Positioned for Growth in 2025 with Strategic Partnerships and Regulatory Progress - TipRanks
Femasys Inc. (FEMY) Reports Q4 Loss, Lags Revenue Estimates - MSN
Femasys earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
Femasys reports FY24 EPS (85c), consensus (81c) - TipRanks
Femasys Inc. FY EPS USD -0.85 - Marketscreener.com
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update - GlobeNewswire
FEMASYS Earnings Preview: Recent $FEMY Insider Trading, Hedge Fund Activity, and More - Nasdaq
FY2026 Earnings Forecast for Femasys Issued By HC Wainwright - Defense World
HC Wainwright Raises Femasys (NASDAQ:FEMY) Price Target to $15.00 - The AM Reporter
HC Wainwright Boosts Femasys (NASDAQ:FEMY) Price Target to $15.00 - Defense World
H.C. Wainwright raises Femasys stock price target to $15 By Investing.com - Investing.com Australia
Femasys price target raised to $15 from $12 at H.C. Wainwright - Yahoo Finance
H.C. Wainwright raises Femasys stock price target to $15 - Investing.com
Femasys (FEMY) to Release Earnings on Thursday - Defense World
Femasys Gains Momentum with EU Approval and Strategic Partnerships, Boosting Buy Rating - TipRanks
Femasys Announces Partnership with CNY Fertility, National - GlobeNewswire
Femasys Secures Game-Changing Partnership: FemaSeed Now Available at 11 Leading Fertility Centers - StockTitan
Femasys’s Strategic Expansion and Promising Clinical Results Justify Buy Rating - TipRanks
Assessing Femasys: Insights From 4 Financial Analysts - Benzinga
Femasys Signs FemBloc Commercial Distribution Deals -March 18, 2025 at 09:58 am EDT - Marketscreener.com
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain - GlobeNewswire
Femasys Breaks Into European Market: First Global Deal for Revolutionary Birth Control Solution - StockTitan
HC Wainwright Reiterates “Buy” Rating for Femasys (NASDAQ:FEMY) - Defense World
H.C. Wainwright maintains Femasys stock Buy rating, $12 target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Femasys stock Buy rating, $12 target - Investing.com
Femasys gains CE mark for non-surgical birth control system By Investing.com - Investing.com Australia
Femasys Achieves CE Mark for FemBloc, Paving the Way for European Market Entry and Justifying Buy Rating - TipRanks
Femasys Receives CE Mark for FemBloc Non-Surgical Permanent Birth Control System - Femtech Insider
1.08%
자본화:
|
볼륨(24시간):